Kario, Kazuomi
Mahfoud, Felix
Kandzari, David E.
Townsend, Raymond R.
Weber, Michael A.
Schmieder, Roland E.
Tsioufis, Konstantinos
Pocock, Stuart
Brar, Sandeep
Hettrick, Douglas A.
Fahy, Martin
Böhm, Michael
Article History
Received: 15 August 2022
Revised: 6 September 2022
Accepted: 7 September 2022
First Online: 15 October 2022
Compliance with ethical standards
:
: Prof KK receives personal fees from Medtronic during the conduct of the study. He reports research funding from Otsuka holdings; honoraria from Otsuka Medical Device, JIMRO and Terumo, outside the submitted work. Prof FM is supported by Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Forschungsgemeinschaft (SFB TRR219), and Deutsche Herzstiftung. He has received scientific support from Medronic and ReCor Medical and speaker honoraria from Astra-Zeneca, Bayer, Boehringer Ingelheim, Inari, Medtronic, Merck, and ReCor Medical. Dr DEK reports institutional research/grant support from Biotronik, Boston Scientific, Cardiovascular Systems, Inc., Orbus Neich, Teleflex, Medtronic and Ablative Solutions; and personal consulting honoraria from Ablative Solutions, Cardiovascular Systems, Inc., Magenta Medical, Medtronic, and Terumo. Prof RRT is a consultant for Medtronic, AXIO and Janssen, and receives royalties from UpToDate. Prof MAW is a consultant for Medtronic, ReCor, Ablative Solutions, Johnson & Johnson and Urovant. Prof RES reports grants and personal fees from Medtronic, Recor, and Ablative Solutions. Prof KT has received scientific support and speaker honoraria from Servier, Novartis,Astra-Zeneca, Bayer, Boehringer Ingelheim, Amgen, Pfizer, Viatris, Menarini, Medtronic and ReCor Medical. Dr SP reports personal fees from Medtronic outside the submitted work. Dr SB, Dr DAH, and Mr MF are employees of Medtronic. Prof MB is supported by the Deutsche Forschungsgemeinschaft (German Research Foundation; TTR 219, project number 322900939) and reports personal fees from Abbott, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Medtronic, Novartis, ReCor Medical, Servier, and Vifor during the conduct of the study.